An innovative approach for HLA typing, molecular tumor testing and the validation of tumor exclusive antigens
Ghosh, M.; Bichmann, L.; Scheid, J.; Gueler, G.; Schuster, H.; Di Marco, M.; Marcu, A.; Beyer, M.; Nelde, A.; Freudenmann, L. K.; Muehlenbruch, L.; Loeffler, M. W.; Kohlbacher, O.; Rammensee, H.-G.; Stevanovic, S.
Show abstract
DisclaimerThis manuscript has been withdrawn by the corresponding author, as it was submitted and made public in bioRxiv without knowledge and the full consent of all the authors listed. The co-authors are therefore not responsible for the contents of this manuscript. For this reason, the submitting author has chosen to withdraw this preprint as a precautionary measure and would like to state that this work should not be cited as a reference. For any related questions that may arise, please contact the corresponding author.Competing Interest StatementThe authors have declared no competing interest.
Matching journals
The top 5 journals account for 50% of the predicted probability mass.